OncoCare Medical (“OncoCare”) is one of the largest private oncology practices in Singapore, providing comprehensive consulting, diagnosis, and treatment services across various subspecialties. At the time of investment, OncoCare operates 7 clinics with 12 highly reputable oncologists.
Novena Heart Centre (“NHC”) is one of the leading multi-disciplinary cardiology group practices in Singapore, specializing in coronary intervention, heart rhythm management, heart failure, cardiac imaging, and cardiothoracic surgery. At the time of investment, NHC consists of 3 cardiology clinics with 5 cardiologists covering various subspecialties.
Who we partnered with
65 Equity Partners partnered with Templewater, a Hong Kong-based private equity firm, on their acquisition of OncoCare and NHC. 65 Equity Partners is committed to working closely with doctors and management to support the platform’s continued excellence and international expansion.
What attracted us to the business
OncoCare and NHC have quality business fundamentals stemming from market leading practices and specialists, and hence are well-positioned to capitalize on secular tailwinds of aging population, the rise in private healthcare spending, and Singapore’s status as a leading medical hub. We are excited about the opportunity to work with our shareholder partner and doctors to grow the group into a leading regional healthcare platform headquartered in Singapore.
Our value creation strategy
We aim to leverage our connections with the Singapore and Southeast Asia healthcare sector as well as our international market access to support both organic and inorganic growth initiatives, to enhance operations, and to build a leading specialty healthcare platform delivering best-in-class healthcare services to an even broader patient base in the region.